Lund­beck dou­bled its of­fer for Long­board over six months, new fil­ing shows

Dan­ish phar­ma Lund­beck vast­ly in­creased its of­fer to buy Long­board Phar­ma­ceu­ti­cals over six months as oth­er par­ties came to the deal­mak­ing ta­ble, a new SEC …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER